Latest News

The Elizabeth Holmes Trial: Former Schering-Plough Scientist Cites Theranos Founder’s ‘Cagey’ Behavior


For the second time since the trial of Elizabeth Holmes began, the jury heard testimony Tuesday that Theranos Inc. altered a document to show investors that its technology had been validated by a major pharmaceutical company.

Constance Cullen, an immunology expert who helped lead test development at pharmaceutical firm Schering-Plough Corp. , testified that she had been unimpressed with Theranos and found Ms. Holmes “cagey” during her process of evaluating the startup’s technology for a possible partnership. Despite that, prosecutors say, Theranos put Schering-Plough’s logo on a document it later gave to a prospective business partner and investor, purporting that the pharmaceutical company had checked out and validated its blood-testing devices.

Former Manchin aides lobbied Congress for oil, gas, pharma while he fought to shrink Biden bills

Previous article

Stimulus checks are coming in 2022 for one group that’s still due COVID relief

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News